Sun Pharma: Outcome of board meeting
The Board of Directors of the Company at their meeting held today duly approved and took on record the limited reviewed Unaudited Standalone Financial Results and Unaudited Consolidated Financial Results for the first quarter ended June 30, 2017 which are enclosed herewith along with the Limited Review Report of the Auditors on Standalone and Consolidated Financial Results.
The meeting of the Board of Directors commenced at 10:50 a.m. and concluded at 3:20 p.m.
This is for your information and record.
Source : BSE